Jeffrey W. Albers is Director of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Mar 04, 2021, when has been sold 10,000 shares (Common Stock) at a price of $8.8 per share, resulting in proceeds of $88,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Jeffrey W. Albers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2021
BUY
Exercise of conversion of derivative security
$88,000 $8.8 p/Share
10,000 Added 4.96%
191,434 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 18.06%
181,434 Common Stock
Dec 14 2020
SELL
Open market or private sale
$595,900 $119.18 p/Share
5,000 Reduced 3.41%
141,434 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$44,000 $8.8 p/Share
5,000 Added 3.3%
146,434 Common Stock
Nov 16 2020
SELL
Open market or private sale
$1,977,000 $98.85 p/Share
20,000 Reduced 12.39%
141,434 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
$176,000 $8.8 p/Share
20,000 Added 11.02%
161,434 Common Stock
Oct 07 2020
SELL
Open market or private sale
$495,850 $99.17 p/Share
5,000 Reduced 3.41%
141,434 Common Stock
Oct 07 2020
BUY
Exercise of conversion of derivative security
$44,000 $8.8 p/Share
5,000 Added 3.3%
146,434 Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
KYMR
Kymera Therapeutics, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
JWA

Jeffrey W. Albers

Director
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC